Biogen Idec

Biogen Idec

March 09, 2005 16:32 ET

Biogen Idec Announces Management Change


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: BIOGEN IDEC

NASDAQ SYMBOL: BIIB

MARCH 9, 2005 - 16:32 ET

Biogen Idec Announces Management Change

CAMBRIDGE, Mass.--(CCNMatthews - Mar 9, 2005) -

Biogen Idec Inc. (NASDAQ: BIIB) announced today that Thomas Bucknum,
Executive Vice President and General Counsel, has resigned from the
company. The resignation is effective immediately.

About Biogen Idec

Biogen Idec creates new standards of care in oncology and immunology. As
a global leader in the development, manufacturing, and commercialization
of novel therapies, Biogen Idec transforms scientific discoveries into
advances in human healthcare. For product labeling, press releases and
additional information about the company, please visit www.biogenidec.com

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    Biogen Idec
    Media Contacts:
    Jose Juves, 617-914-6524
    Associate Director, Public Affairs
    or
    Investor Relations
    Elizabeth Woo, 617-679-2812
    Senior Director, Investor Relations